Jazz Pharmaceuticals JAZZ Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseCurrent.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's prepaid & other current?
- Jazz Pharmaceuticals (JAZZ) reported prepaid & other current of $149.7M in Q1 2026.
- How has Jazz Pharmaceuticals's prepaid & other current changed year-over-year?
- Jazz Pharmaceuticals's prepaid & other current decreased by 0.4% year-over-year, from $150.28M to $149.7M.
- What is the long-term trend for Jazz Pharmaceuticals's prepaid & other current?
- Over 5 years (2020 to 2025), Jazz Pharmaceuticals's prepaid & other current has grown at a 19.6% compound annual growth rate (CAGR), from $62.42M to $152.5M.
- What does prepaid & other current mean?
- Payments made for future services or other minor assets expected to be used within a year.
- How do you interpret prepaid & other current?
- Significant fluctuations may indicate changes in operational scale or timing of large service contracts.
- How does prepaid & other current compare across companies?
- Standard accounting line item across all sectors; generally low impact on overall financial health.